mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |